Published in BMC Ophthalmol on June 07, 2007
Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone. Br J Ophthalmol (2009) 1.07
Intravitreal bevacizumab (avastin) for subfoveal neovascular age-related macular degeneration. Int Ophthalmol (2008) 1.05
Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical Trial. J Ophthalmic Vis Res (2015) 0.86
VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration. Jpn J Ophthalmol (2011) 0.85
Future therapies of wet age-related macular degeneration. J Ophthalmol (2015) 0.84
Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2010) 0.80
Vascular endothelial growth factors and their inhibitors in ocular neovascular disorders. J Ophthalmic Vis Res (2009) 0.80
Two-year outcome of photodynamic therapy combined with intravitreal injection of bevacizumab and triamcinolone acetonide for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2012) 0.79
Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration. Jpn J Ophthalmol (2012) 0.79
A systematic review of the relationship between dystemprament (sue Mizaj) and treatments and management of diseases (Ilaj and Eslah-e-Mizaj). Electron Physician (2016) 0.75
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology (2006) 9.01
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol (2001) 7.60
Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina (2000) 2.87
A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol (2003) 2.56
Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology (2005) 2.51
Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci (2003) 1.93
Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration. Retina (2006) 1.91
Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci (2002) 1.75
Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci (2003) 1.69
Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol (2002) 1.61
Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone. Retina (2007) 1.52
Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol (2004) 1.30
Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology (2005) 1.29
Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol (2004) 1.17
Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells. Graefes Arch Clin Exp Ophthalmol (2002) 1.14
Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study). Graefes Arch Clin Exp Ophthalmol (2007) 1.12
Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology (1999) 1.08
Time course and morphology of vascular effects associated with photodynamic therapy. Ophthalmology (2005) 1.01
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study. Br J Ophthalmol (2006) 0.98
Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol (2006) 0.95
Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome. Retina (2006) 0.94
Problems with and pitfalls of photodynamic therapy. Ophthalmology (2000) 0.93
Triamcinolone acetonide suppresses early proangiogenic response in retinal pigment epithelial cells after photodynamic therapy in vitro. Br J Ophthalmol (2006) 0.82
Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration. Acta Ophthalmol Scand (2006) 0.81
Intravitreal triamcinolone reinjection for refractory diabetic macular edema. Korean J Ophthalmol (2006) 0.81
Anatomic and visual outcomes of scleral buckling versus primary vitrectomy in pseudophakic and aphakic retinal detachment: six-month follow-up results of a single operation--report no. 1. Ophthalmology (2005) 3.33
Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema. Ophthalmology (2009) 2.14
Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial. Graefes Arch Clin Exp Ophthalmol (2007) 1.64
Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2008) 1.59
The status of serum vitamin D in patients with active Behcet's disease compared with controls. Int J Rheum Dis (2013) 1.47
Prevalence of diabetic retinopathy in Tehran province: a population-based study. BMC Ophthalmol (2009) 1.34
Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Retina (2007) 1.22
Surgical management of non-metallic and non-magnetic metallic intraocular foreign bodies. Ophthalmic Surg Lasers Imaging (2005) 1.12
Idiopathic retinal vasculitis, aneurysms and neuroretinitis syndrome associated with positive perinuclear antineutrophil cytoplasmic antibody. J Ophthalmic Vis Res (2011) 1.09
Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma. Ophthalmic Surg Lasers Imaging (2007) 1.03
Childhood pars planitis; clinical features and outcomes. J Ophthalmic Vis Res (2011) 1.02
Optical coherence tomographic findings in highly myopic eyes. J Ophthalmic Vis Res (2010) 1.01
Confocal scan features of keratic precipitates in Fuchs heterochromic iridocyclitis. Cornea (2010) 0.99
Increased Latency of Visual Evoked Potentials in Healthy Women during Menstruation. J Ophthalmic Vis Res (2011) 0.98
Neurologic complications in percutaneous nephrolithotomy. Korean J Urol (2013) 0.98
Patterns of uveitis in the middle East and europe. J Ophthalmic Vis Res (2011) 0.98
Clinical features and surgical outcomes of pediatric rhegmatogenous retinal detachment. Retina (2009) 0.97
Sustained release intraocular drug delivery devices for treatment of uveitis. J Ophthalmic Vis Res (2011) 0.94
Long-term surgical outcome of posterior choroidal melanoma treated by endoresection. Retina (2007) 0.94
Spectral-domain optical coherence tomography features of mild and severe acute solar retinopathy. Ophthalmic Surg Lasers Imaging (2011) 0.93
Confocal scan of keratic precipitates in uveitic eyes of various etiologies. Cornea (2010) 0.92
Large juxtafoveal telangiectasia. J Ophthalmic Vis Res (2010) 0.91
SD-OCT features of laser pointer maculopathy before and after systemic corticosteroid therapy. Ophthalmic Surg Lasers Imaging (2011) 0.91
Posttraumatic endophthalmitis: report No. 2. Retina (2012) 0.90
Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration. J Ophthalmic Vis Res (2008) 0.89
Confocal Scan Features of Keratic Precipitates in Granulomatous versus Nongranulomatous Uveitis. J Ophthalmic Vis Res (2011) 0.89
Pain score of patients undergoing single spot, short pulse laser versus conventional laser for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2012) 0.89
Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1). Graefes Arch Clin Exp Ophthalmol (2010) 0.88
Prone position in percutaneous nephrolithotomy and postoperative visual loss. Urol J (2011) 0.88
Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol (2006) 0.87
Surgical management of retinal detachment in highly myopic eyes with macular hole. Ophthalmic Surg Lasers Imaging (2007) 0.87
Enhancing the dyeability of polypropylene fibers by melt blending with polyethylene terephthalate. ScientificWorldJournal (2013) 0.86
Surgical management of retinal detachment secondary to acute retinal necrosis: clinical features, surgical techniques, and long-term results. Jpn J Ophthalmol (2003) 0.86
Rapid regression of extensive retinovitreal neovascularization secondary to branch retinal vein occlusion after a single intravitreal injection of bevacizumab. Int Ophthalmol (2007) 0.86
Hyperhomocysteinemia and central retinal vein occlusion in Iranian population. Int Ophthalmol (2007) 0.85
Bilateral primary intraocular lymphoma. J Ophthalmic Vis Res (2011) 0.85
Causes of visual impairment among patients referred to a visual rehabilitation clinic in Iran. Korean J Ophthalmol (2012) 0.85
Laparoscopic vesicovaginal fistula repair: report of five cases, literature review, and pooling analysis. J Laparoendosc Adv Surg Tech A (2012) 0.84
Retinopathy of Prematurity: Single versus Multiple-Birth Pregnancies. J Ophthalmic Vis Res (2008) 0.84
Loss of vision once silicone oil has been removed. Retina (2005) 0.83
Clinical Patterns of Uveitis in an Iranian Tertiary Eye-care Center. Ocul Immunol Inflamm (2014) 0.83
Percutaneous nephrolithotomy in high-risk patients: a single-center experience with more than 350 cases. Urol Int (2013) 0.83
Topiramate-induced bilateral anterior uveitis associated with hypopyon formation. Ocul Immunol Inflamm (2010) 0.83
Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Retina (2010) 0.83
The effect of combinations of flurbiprofen, low molecular weight heparin, and doxycycline on the inhibition of corneal neovascularization. Cornea (2006) 0.82
Long-term outcome of trans urethral prostatectomy in benign prostatic hyperplasia patients with and without diabetes mellitus. J Pak Med Assoc (2010) 0.82
Effect of oral prednisolone on visual outcomes and complications after scleral buckling. Eur J Ophthalmol (2010) 0.82
Medulloepithelioma masquerading as chronic anterior granulomatous uveitis. Can J Ophthalmol (2007) 0.82
Intravitreal diclofenac for refractory uveitic cystoid macular edema. J Ophthalmic Vis Res (2013) 0.82
Enhanced depth imaging OCT (EDI-OCT) findings in acute phase of sympathetic ophthalmia. Int Ophthalmol (2015) 0.81
Concomitant optic nerve transection and chorioretinitis sclopetaria. BMC Ophthalmol (2005) 0.81
Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent-onset branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2012) 0.80
Laparoscopic management of caliceal diverticulum: our experience, literature review, and pooling analysis. J Endourol (2013) 0.80
The EFFEct of HESA-A (natural drug) on visual acuity in age related macular degeneration: a randomized double blind controlled clinical trial. Afr J Tradit Complement Altern Med (2009) 0.79
Ultrasound biomicroscopy findings in fireworks-related blunt eye injuries. Eur J Ophthalmol (2012) 0.79
Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy. Pediatr Blood Cancer (2012) 0.79
Autofluorescence Imaging for Diagnosis and Follow-up of Cystoid Macular Edema. J Ophthalmic Vis Res (2012) 0.79
Intravitreal toxicity of levofloxacin and gatifloxacin. Ophthalmic Surg Lasers Imaging (2006) 0.79
Retinopathy of prematurity in infants with late retinal examination. J Ophthalmic Vis Res (2009) 0.79
Management of magnetic intravitreal foreign bodies in 71 eyes. Ophthalmic Surg Lasers Imaging (2004) 0.79
Enhanced depth imaging OCT and indocyanine green angiography changes in acute macular neuroretinopathy. Ophthalmic Surg Lasers Imaging Retina (2013) 0.79
Bilateral perirenal subcapsular fluid collection: a rare presentation of renal parenchymal disease. Urol J (2010) 0.78
Delayed postpercutaneous nephrolithotomy hemorrhage: prevalence, predictive factors and management. Scand J Urol (2013) 0.78
Electroretinogram Changes following Silicone Oil Removal. J Ophthalmic Vis Res (2011) 0.78
Optical Coherence Tomography Angiography in Foveal Hypoplasia. Ophthalmic Surg Lasers Imaging Retina (2016) 0.77
Oxygen therapy for diabetic macular ischemia: a pilot study. Retina (2011) 0.77
Outcomes of retinal detachment surgery in eyes with chorioretinal coloboma. J Ophthalmic Vis Res (2010) 0.77
Influence of intravitreal triamcinolone acetonide injection in scleral buckling surgery for macula-off retinal detachment. Ophthalmic Res (2014) 0.77
Surgery for optic neuropathy. Ophthalmology (2008) 0.77
Intravitreal triamcinolone for acute branch retinal vein occlusion: a randomized clinical trial. J Ophthalmic Vis Res (2011) 0.77
Spectral-domain optical coherence tomography appearance of a retinal nematode. Ophthalmic Surg Lasers Imaging Retina (2013) 0.77
Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent onset central retinal vein occlusion. Acta Ophthalmol (2013) 0.77
Posttraumatic endophthalmitis. Ophthalmology (2005) 0.77